Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial
Phase of Trial: Phase III
Latest Information Update: 22 Jul 2014
At a glance
- Drugs Ganirelix (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms DOS/DOR
- 10 Jun 2014 According to the ClinicalTrials.gov record, status changed from recruiting to discontinued.
- 03 Jun 2013 Planned end date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 13 Jun 2012 New trial record